A citation-based method for searching scientific literature

Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram, Donald M Parkin, Marion Piñeros, Ariana Znaor, Freddie Bray. Int J Cancer 2021
Times Cited: 729







List of co-cited articles
130 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
34

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019
7

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
6

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
5

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
5

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
4

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
4

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
3

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
3

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Jordi Bruix, Shukui Qin, Philippe Merle, Alessandro Granito, Yi-Hsiang Huang, György Bodoky, Marc Pracht, Osamu Yokosuka, Olivier Rosmorduc, Valeriy Breder,[...]. Lancet 2017
3

Sorafenib in advanced hepatocellular carcinoma.
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme de Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner,[...]. N Engl J Med 2008
3

Cancer drug resistance: an evolving paradigm.
Caitriona Holohan, Sandra Van Schaeybroeck, Daniel B Longley, Patrick G Johnston. Nat Rev Cancer 2013
3


Triple-negative breast cancer.
William D Foulkes, Ian E Smith, Jorge S Reis-Filho. N Engl J Med 2010
3

Drug resistance in cancer: an overview.
Genevieve Housman, Shannon Byler, Sarah Heerboth, Karolina Lapinska, Mckenna Longacre, Nicole Snyder, Sibaji Sarkar. Cancers (Basel) 2014
3

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
3

Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells.
Ana Paula Braga Lima, Tamires Cunha Almeida, Tatiane Martins Barcelos Barros, Lorrana Cachuite Mendes Rocha, Camila Carriao Machado Garcia, Glenda Nicioli da Silva. Mutagenesis 2020
7
28

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Andrew X Zhu, Yoon-Koo Kang, Chia-Jui Yen, Richard S Finn, Peter R Galle, Josep M Llovet, Eric Assenat, Giovanni Brandi, Marc Pracht, Ho Yeong Lim,[...]. Lancet Oncol 2019
792
2


Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
Ghassan K Abou-Alfa, Tim Meyer, Ann-Lii Cheng, Anthony B El-Khoueiry, Lorenza Rimassa, Baek-Yeol Ryoo, Irfan Cicin, Philippe Merle, YenHsun Chen, Joong-Won Park,[...]. N Engl J Med 2018
2

Chemotherapy for hepatocellular carcinoma: The present and the future.
Marco Le Grazie, Maria Rosa Biagini, Mirko Tarocchi, Simone Polvani, Andrea Galli. World J Hepatol 2017
102
2

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang,[...]. Lancet Oncol 2009
2

Hepatocellular carcinoma.
Josep M Llovet, Robin Kate Kelley, Augusto Villanueva, Amit G Singal, Eli Pikarsky, Sasan Roayaie, Riccardo Lencioni, Kazuhiko Koike, Jessica Zucman-Rossi, Richard S Finn. Nat Rev Dis Primers 2021
985
2

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Richard S Finn, Shukui Qin, Masafumi Ikeda, Peter R Galle, Michel Ducreux, Tae-You Kim, Masatoshi Kudo, Valeriy Breder, Philippe Merle, Ahmed O Kaseb,[...]. N Engl J Med 2020
2

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
2

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
2

Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.
Katrin Knop, Richard Hoogenboom, Dagmar Fischer, Ulrich S Schubert. Angew Chem Int Ed Engl 2010
2

A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer.
Miyuki Ono, James M Ogilvie, Jennifer S Wilson, Heather J Green, Suzanne K Chambers, Tamara Ownsworth, David H K Shum. Front Oncol 2015
84
2




Emotional distress and dysfunctional illness perception are associated with low mental and physical quality of life in Chinese breast cancer patients.
Lili Tang, Kurt Fritzsche, Rainer Leonhart, Ying Pang, Jinjiang Li, Lili Song, Irmela Fischer, Maike Koch, Alexander Wuensch, Ricarda Mewes,[...]. Health Qual Life Outcomes 2017
23
8


Modulation of Interhemispheric Functional Coordination in Breast Cancer Patients Receiving Chemotherapy.
Longxiang Tao, Lu Wang, Xingui Chen, Fujun Liu, Feiyan Ruan, Jingjie Zhang, Li Shen, Yongqiang Yu. Front Psychol 2020
5
40

Skeletal muscle loss and prognosis of breast cancer patients.
Yoshiko Kubo, Tateaki Naito, Keita Mori, Gakuji Osawa, Etsuko Aruga. Support Care Cancer 2017
21
9


Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study.
Helle Pappot, Christina W Baeksted, Aase Nissen, Ann Knoop, Sandra A Mitchell, Jane Christensen, Niels Henrik Hjollund, Christoffer Johansen. Breast Cancer 2021
4
50

Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis.
E A Underwood, P A Rochon, R Moineddin, P E Lee, W Wu, K I Pritchard, M C Tierney. Breast Cancer Res Treat 2018
39
5


Disrupted brain network functional dynamics and hyper-correlation of structural and functional connectome topology in patients with breast cancer prior to treatment.
Shelli R Kesler, Marjorie Adams, Melissa Packer, Vikram Rao, Ashley M Henneghan, Douglas W Blayney, Oxana Palesh. Brain Behav 2017
52
3

Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.
Jasmine Eshragh, Anand Dhruva, Steven M Paul, Bruce A Cooper, Judy Mastick, Deborah Hamolsky, Jon D Levine, Christine Miaskowski, Kord M Kober. J Pain Symptom Manage 2017
22
9

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Ian R Kleckner, Charles Kamen, Jennifer S Gewandter, Nimish A Mohile, Charles E Heckler, Eva Culakova, Chunkit Fung, Michelle C Janelsins, Matthew Asare, Po-Ju Lin,[...]. Support Care Cancer 2018
121
2

Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
Ting Bao, Coby Basal, Christina Seluzicki, Susan Q Li, Andrew D Seidman, Jun J Mao. Breast Cancer Res Treat 2016
162
2

Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
Kimberly D van der Willik, Vincent Koppelmans, Michael Hauptmann, Annette Compter, M Arfan Ikram, Sanne B Schagen. Breast Cancer Res 2018
58
3

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.
Neil Majithia, Sarah M Temkin, Kathryn J Ruddy, Andreas S Beutler, Dawn L Hershman, Charles L Loprinzi. Support Care Cancer 2016
67
2

Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050.
Sophie Pilleron, Enrique Soto-Perez-de-Celis, Jerome Vignat, Jacques Ferlay, Isabelle Soerjomataram, Freddie Bray, Diana Sarfati. Int J Cancer 2021
74
2

Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise.
Semini Sumanasuriya, Johann De Bono. Cold Spring Harb Perspect Med 2018
79
2

Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2016
2

Current trends and emerging diagnostic techniques for lung cancer.
Bala Prabhakar, Pravin Shende, Steffi Augustine. Biomed Pharmacother 2018
25
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.